NEW YORK CITY, NY / ACCESS Newswire / January 24, 2025 / Pomerantz LLP is investigating claims on behalf of investors of IGM Biosciences, Inc. ("IGM" or the "Company") (NASDAQ:IGMS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.comâ?¯or 646-581-9980, ext.â?¯7980. The investigation concerns whether IGM and certain of its officers and/or directors have […]
NEW YORK, NY / ACCESS Newswire / January 24, 2025 / Pomerantz LLP is investigating claims on behalf of investors of 4D Molecular Therapeutics, Inc. ("4D" or the "Company") (NASDAQ:FDMT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether 4D and certain of its officers and/or
NEW YORK CITY, NY / ACCESS Newswire / January 24, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Aehr Test Systems, Inc. ("Aehr" or the "Company") (NASDAQ:AEHR) and certain officers. The class action, filed in the United States District Court for the Northern District of California, and docketed under
NEW YORK, NY / ACCESS Newswire / January 24, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Micron Technology, Inc. ("Micron" or the "Company") (NASDAQ:MU) and certain officers. The class action, filed in the United States District Court for the Southern District of Florida, and docketed under 25-cv-80040, is
NEW YORK, NY / ACCESS Newswire / January 24, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Crocs, Inc. ("Crocs" or the "Company") (NASDAQ:CROX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to
Asheville, Jan. 24, 2025 (GLOBE NEWSWIRE) — Asheville, North Carolina – Dr. Eric Halvorson of Halvorson Plastic Surgery was selected as the 2025 President of the North Carolina Society of Plastic Surgeons. The North Carolina Society of Plastic Surgeons represents the collective expertise and dedication of board-certified plastic surgeons across the state. Established in 1977,
NEW YORK, NY / ACCESS Newswire / January 24, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Spyre Therapeutics, Inc. ("Spyre" or the "Company") (NASDAQ:SYRE). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Spyre and certain of its officers and/or directors
NEW YORK, NY / ACCESS Newswire / January 24, 2025 / Pomerantz LLP is investigating claims on behalf of investors of PepGen Inc. ("PepGen" or the "Company") (NASDAQ:PEPG). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether PepGen and certain of its officers and/or directors have
NEW YORK, NY / ACCESS Newswire / January 24, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Codere Online Luxembourg, S.A. ("Codere" or the "Company") (NASDAQ:CDRO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Codere and certain of its officers and/or
NEW YORK, NY / ACCESS Newswire / January 24, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Oklo Inc. ("Oklo" or the "Company") (NYSE:OKLO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Oklo and certain of its officers and/or directors have